A potent anti-inflammatory peptide derived from alpha-MSH that effectively targets inflammation in the gut and skin, often used for IBS and psoriasis.
KPV is a short anti-inflammatory peptide derived from alpha-MSH (melanocyte-stimulating hormone). It has been studied for its ability to modulate inflammatory signaling pathways and reduce cytokine-driven immune activation. Unlike broad immune suppressants, KPV is investigated for its targeted anti-inflammatory effects, particularly in the gut and skin.
KPV may be considered for individuals experiencing localized inflammatory conditions, particularly involving the gastrointestinal tract or skin. Individuals with IBS-like symptoms or gut inflammation. Those experiencing inflammatory skin conditions such as psoriasis or dermatitis. Patients with food-triggered immune reactivity. Individuals seeking targeted immune modulation without systemic suppression.
